GlassScriptPhysician profile
Sarah E Andrews
NPI 1346240603
$3,765.01
in general payments reported to CMS, 2019-2025
34 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $367 · 2021: $935 · 2022: $714 · 2023: $566 · 2024: $353 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $643.11 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Pfizer INC. | $518.09 | 2019-2024 | |
| Coopersurgical, INC. | $324.27 | 2019-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $316.77 | 2019-2022 | |
| Exeltis, USA INC. | $292.98 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $257.85 | 2022-2025 | |
| Myovant Sciences INC. | $155.44 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $149.32 | 2023-2025 | Myfembree |
| Medtronic, INC. | $136.26 | 2023 | Ligasure |
| Evofem Biosciences, INC. | $103.13 | 2021-2024 | |
| Hologic Sales and Service, LLC | $90.85 | 2022-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Merck Sharp & Dohme LLC | $89.47 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $83.59 | 2019-2020 | |
| Allergan, INC. | $81.40 | 2019-2020 | |
| Avion Pharmaceuticals | $69.71 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $66.58 | 2023-2025 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $53.37 | 2022-2023 | Twirla |
| Organon LLC | $41.16 | 2021-2024 | |
| Astellas Pharma US INC | $37.28 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $34.63 | 2024 | |
| Ethicon US, LLC | $22.19 | 2019 | |
| Lupin INC. | $20.00 | 2020 | |
| Mycovia Pharmaceuticals, INC. | $18.70 | 2023 | Vivjoa |
| Mylan Specialty L.P. | $18.00 | 2022 | |
| Duchesnay USA Incorporated | $17.50 | 2019 | |
| Scynexis, INC. | $17.07 | 2022 | |
| Teleflex LLC | $15.49 | 2024 | Quikclot |
| Biohaven Pharmaceutical Holding Company LTD. | $14.74 | 2022 | |
| Mimedx Group, INC. | $13.79 | 2025 | |
| Exact Sciences Corporation | $13.10 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $13.08 | 2021 | |
| Shield Therapeutics INC | $12.61 | 2022 | |
| Currax Pharmaceuticals LLC | $12.26 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.